ClinicalTrials.gg
Sign In
Status unknownNCT01587456ARTEOS2Updated Jun 16, 2016

Arteos II Study: Relationship Between Osteoporosis and Arterial Rigidity Within Fractured Patients Cohort

An observational study in Osteoporosis, sponsored by Central Hospital, Nancy, France. Status unknown at 1 site in France. Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2016-06-16.

Sponsored by Central Hospital, Nancy, France · Observational

The sponsor has not verified this record recently (last verified Jun 2016), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
300
Ages
60 Years and older
Sex
All
01

Study summary

The investigators planned to study relationship between osteoporosis and arterial rigidity within fractured patients cohort.

02

Conditions studied

  • Osteoporosis

Browse trials for

Keywords

  • Osteoporosis
03

In context

Osteoporosis

1,675 studies on the registry are indexed under Osteoporosis; 211 are open to participants now.

This study's planned enrollment of 300 is above the median of 180 across 461 observational studies indexed under Osteoporosis.

Browse Osteoporosis studies →

Lead sponsor

Central Hospital, Nancy, France is the lead sponsor of 796 studies on the registry; 187 are open to participants now.

Browse Central Hospital, Nancy, France studies →

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Women and men > 60 years of age with medical history of low energy fracture andradiologic osteoporosis with DXA Tscore at -2,5 DS.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • women and men > 60 years of age
  • medical history of low energy fracture
  • DXA Tscore -2,5 DS
  • FREE AND INFORMED CONSENT SIGNED

Exclusion criteria

Exclusion Criteria:

  • women and men \< 60 years of age
  • Corticoids treatment
  • Breast cancer or prostat cancer medical history
  • High energy fracture (traumatic fracture)
  • No social security affiliation
  • Incapacity to informed consent signed.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
300 participants (estimated)
Biospecimen retention
Samples with dna
06

Study locations

1 of 1 sites recruiting
  • CHU de Brabois Endocrinology
    Vandœuvre-lès-Nancy, 54500, France
    • Georges WERYHA, Professor · Contact · g.weryha@chu-nancy.fr · 33 3 83 15 35 05
    • Anna KEARNEY-SCHWARTZ, Doctor · Contact · a.kearney-schwartz@chu-nancy.fr · 33 3 83 15 33 22
    • Georges WERYHA, Professor · Principal investigator
    • Anna KEARNEY SCHWARTZ, Doctor · Sub investigator
    • Anna ANGELOUSI, Doctor · Sub investigator
    • Athanase BENETOS, Professor · Sub investigator
    • Shiva KHORSAND, Doctor · Sub investigator
    • Lelia GROZA, Doctor · Sub investigator
    • Eva FEIGERLOVA, Doctor · Sub investigator
    • Paolo SALVI, Professor · Sub investigator
    Recruiting
07

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Apr 2012, a primary completion of Apr 2017 and a completion of Apr 2017. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 26, 2012
First posted
Apr 30, 2012
Start
Apr 2012
Primary completionEst.
Apr 2017
CompletionEst.
Apr 2017
Last update
Jun 16, 2016
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 16, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01587456
Lead sponsor
Central Hospital, Nancy, France
Responsible party
Sponsor
First posted
Apr 30, 2012
Start date
Apr 2012
Primary completion
Apr 2017 (estimated)
Completion
Apr 2017 (estimated)
Last update
Jun 16, 2016

Study contacts

Georges WERYHA, MD, PHD
Contact
g.weryha@chu-nancy.fr
33 3 83 15 35 05
Anna KEARNEY SCHWARTZ, MD
Contact
a.kearney-schwartz@chu-nancy.fr
+33 3 83 15 33 22
Georges WERYHA, Professor
principal investigator · CHU de Brabois Endocrinology

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jun 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Osteoporosis →

Other studies from this sponsor

Central Hospital, Nancy, France →

Start the discussion